A major 12-year study based on a Taiwanese population cohort has demonstrated that not only does diabetes increase the risk of developing Parkinson's disease more than twofold, the use of sulfonylureas, commonly used as treatment for diabetes, increases the risk further by about 57 percent. This study also found that by including metformin in the therapy, no increased risk in developing Parkinson's disease was recorded.
- Metformin can substantially reduce the risk of Parkinson's disease in diabetesWed, 18 Apr 2012, 20:32:43 EDT
- Using amphetamines may increase risk of Parkinson's diseaseSun, 20 Feb 2011, 16:33:19 EST
- A decade later, lifestyle changes or metformin still lower type 2 diabetes riskWed, 28 Oct 2009, 18:51:22 EDT
- Years of smoking associated with lower Parkinson's risk, not number of cigarettes per dayWed, 10 Mar 2010, 16:31:30 EST
- Inhaled corticosteroids increase diabetes mellitus riskTue, 14 Dec 2010, 13:07:18 EST